220 related articles for article (PubMed ID: 8634088)
21. Invasiveness and metastatic capability of rat fibroblast-like cells before and after transfection with immortalizing and transforming genes.
Van Roy FM; Messiaen L; Liebaut G; Gao J; Dragonetti CH; Fiers WC; Mareel MM
Cancer Res; 1986 Sep; 46(9):4787-95. PubMed ID: 3015398
[TBL] [Abstract][Full Text] [Related]
22. Resistance of murine LTA cells to oncogene--mediated progression from tumorigenic to metastatic phenotype.
Tuck AB; Wilson SM; Chambers AF
Anticancer Res; 1990; 10(6):1507-14. PubMed ID: 2285224
[TBL] [Abstract][Full Text] [Related]
23. Selection for spontaneous metastasis after calcium phosphate-mediated transfer of DNA.
Muschel RJ
Cancer Res; 1990 Sep; 50(17):5581-6. PubMed ID: 2201438
[TBL] [Abstract][Full Text] [Related]
24. Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells.
Melchiori A; Carlone S; Allavena G; Aresu O; Parodi S; Aaronson SA; Albini A
Anticancer Res; 1990; 10(1):37-44. PubMed ID: 2334141
[TBL] [Abstract][Full Text] [Related]
25. Morphological transformation, tumorigenicity and src-specific cytotoxic T-lymphocyte-mediated tumor immunity induced by murine 3T3 cells expressing src oncogenes encoding novel non-myristylated N-terminal domains.
Gelman IH; Khan S; Hanafusa H
Oncogene; 1993 Nov; 8(11):2995-3004. PubMed ID: 7692370
[TBL] [Abstract][Full Text] [Related]
26. Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells.
Tatosyan A; Yatsula B; Shtutman M; Moinova E; Kaverina I; Musatkina E; Leskov K; Mizenina O; Zueva E; Calothy G; Dezélée P
Virology; 1996 Feb; 216(2):347-56. PubMed ID: 8607264
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous transfer of tumorigenic and metastatic phenotypes by transfection with genomic DNA from a human cutaneous squamous cell carcinoma.
Ananthaswamy HN; Price JE; Goldberg LH; Bales ES
J Cell Biochem; 1988 Feb; 36(2):137-46. PubMed ID: 3356753
[TBL] [Abstract][Full Text] [Related]
28. Clonal diversity of the Kirsten-ras oncogene during tumor progression in athymic nude mice: mechanisms of amplification and rearrangement.
Radinsky R; Kraemer PM; Proffitt MR; Culp LA
Cancer Res; 1988 Sep; 48(17):4941-53. PubMed ID: 3409227
[TBL] [Abstract][Full Text] [Related]
29. Ras-responsive genes and tumor metastasis.
Chambers AF; Tuck AB
Crit Rev Oncog; 1993; 4(2):95-114. PubMed ID: 8420573
[TBL] [Abstract][Full Text] [Related]
30. [Antisense TIF3 reverses the oncogenic potential of CdCl2-transformed BALB/c-3T3 cells].
Lei Y; Pius J; Wu Z; Ong TM
Wei Sheng Yan Jiu; 2002 Aug; 31(4):255-7. PubMed ID: 12600033
[TBL] [Abstract][Full Text] [Related]
31. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme.
Kashani-Sabet M; Funato T; Florenes VA; Fodstad O; Scanlon KJ
Cancer Res; 1994 Feb; 54(4):900-2. PubMed ID: 8313379
[TBL] [Abstract][Full Text] [Related]
32. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis.
Peretz D; Kimel N; Fujii DK; Neufeld G
Cancer Res; 1993 Jan; 53(1):158-64. PubMed ID: 8416740
[TBL] [Abstract][Full Text] [Related]
34. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
[TBL] [Abstract][Full Text] [Related]
35. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
[TBL] [Abstract][Full Text] [Related]
36. Growth factor modulation of metastatic lung colonization.
Egan SE; Jarolim L; Rogelj S; Spearman M; Wright JA; Greenberg AH
Anticancer Res; 1990; 10(5A):1341-6. PubMed ID: 2241111
[TBL] [Abstract][Full Text] [Related]
37. Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
Shumaker DK; Sklar MD; Prochownik EV; Varani J
Exp Cell Res; 1994 Oct; 214(2):440-6. PubMed ID: 7925639
[TBL] [Abstract][Full Text] [Related]
38. Detection of oncogene mRNA sequences in cultured cells by in situ hybridization.
Stoner GD; You M; Skouv J; Budd GC; Pansky B; Wang Y
Ann Clin Lab Sci; 1987; 17(2):74-82. PubMed ID: 3579212
[TBL] [Abstract][Full Text] [Related]
39. Rho proteins induce metastatic properties in vivo.
del Peso L; Hernández-Alcoceba R; Embade N; Carnero A; Esteve P; Paje C; Lacal JC
Oncogene; 1997 Dec; 15(25):3047-57. PubMed ID: 9444953
[TBL] [Abstract][Full Text] [Related]
40. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
Wang B; Soule HD; Miller FR
Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
